Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target

Go back to Wells Fargo Downgrades WuXi PharmaTech (WX) to Market Perform; Valuation Call - Questioning Acquisition Target
CHARLES RIVER LABORATORIE (NYSE: CRL) Delayed: 290.00 +10.81 (3.87%)
Previous Close $279.19    52 Week High $89.18 
Open $284.22    52 Week Low $65.70 
Day High $294.56    P/E 134.88 
Day Low $280.68    EPS $2.15 
Volume 987,427       

Vertex Pharmaceuticals Inc (NASDAQ: VRTX) Delayed: 552.06 +23.87 (4.52%)
Previous Close $528.19    52 Week High $134.71 
Open $537.47    52 Week Low $73.31 
Day High $553.69    P/E N/A 
Day Low $532.55    EPS $-1.98 
Volume 1,437,678       

WUXI PHARMATECH (NYSE: WX) Delayed: 25.00 +0.17 (0.68%)
Previous Close $24.83    52 Week High $46.14 
Open $25.04    52 Week Low $32.50 
Day High $25.04    P/E N/A 
Day Low $25.00    EPS $0.00 
Volume 327